Unraveling the neuroimmune mechanisms in cancer-induced bone pain: New horizons for therapeutic intervention of the two-phase paradigm
Proceedings of the National Academy of Sciences · 26.08.2025 · 122 (34)
DOI: 10.1073/pnas.2503779122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 19.08.2025. Verfasst von Changming Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China. Hauptthemen laut MEDLINE: Cancer Pain, Bone Neoplasms, Neuroimmunomodulation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), development plan of traditional chinese medicine and technology in Jiangsu Province.
Abstract (Originalsprache)
Cancer-induced bone pain (CIBP) is a severely painful condition that profoundly impacts patients’ quality of life. However, the neuroimmune mechanisms underlying CIBP remain largely elusive. Substance P (SP), which is known to play a pivotal role in pain perception, became the focal point of our study. To this end, we adopted a comprehensive approach combining behavioral and physiological methods to investigate its role in neuroimmune interactions in CIBP. The results showed that SP released by dorsal root ganglion (DRG) neurons via exocytosis initiates CIBP, with its release peaking on the 14th day and correlating with pain behavior. Macrophages were found to infiltrate the DRGs and the sciatic nerves. Notably, in mice with CIBP, the population of macrophage type I was significantly augmented. Significantly, we found that the deletion of macrophages led to a notable alleviation of CIBP, while the blockade of the SP-neurokinin 1 receptor pathway effectively mitigated the infiltration of macrophages and alleviated CIBP. In the advanced phase, DRGs released C-C Motif Chemokine Ligand 3 and C-C Motif Chemokine Ligand 2 to recruit macrophages. A two-phase model for CIBP progression in mice was proposed, with SP-induced macrophage infiltration in the primary phase and chemokine-mediated macrophage recruitment in the advanced phase. Our investigation has unearthed a previously unrecognized mechanism governing the neuroimmune interaction in CIBP, which highlights a critical target for impeding the progression of this debilitating pain, potentially opening up broad avenues for the development of effective therapeutic interventions at different stages of CIBP with cancer development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China.
- School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.
- Jiangsu Cancer Hospital, Nanjing 210000, Jiangsu, China.
ORCID-Profile: Changming Wang, Guang Yu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- development plan of traditional chinese medicine and technology in Jiangsu Province
Zitieren
APA
Wang, C., Ji, H., Wang, H., Chen, Z., Zhou, L., Yang, Y., Jiang, Y., Yu, G., Jiang, L., & Tang, Z. (2025). Unraveling the neuroimmune mechanisms in cancer-induced bone pain: New horizons for therapeutic intervention of the two-phase paradigm. Proceedings of the National Academy of Sciences, 122(34). https://doi.org/10.1073/pnas.2503779122
Vancouver
Wang C, Ji H, Wang H, Chen Z, Zhou L, Yang Y, et al. Unraveling the neuroimmune mechanisms in cancer-induced bone pain: New horizons for therapeutic intervention of the two-phase paradigm. Proceedings of the National Academy of Sciences. 2025;122(34). doi:10.1073/pnas.2503779122
BibTeX
@article{Wang2025,
author = {Wang, Changming and Ji, Haiwang and Wang, Hanwen and Chen, Ziyun and Zhou, Lan and Yang, Yan and Jiang, Yucui and Yu, Guang and Jiang, Ling and Tang, Zongxiang},
title = {Unraveling the neuroimmune mechanisms in cancer-induced bone pain: New horizons for therapeutic intervention of the two-phase paradigm},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {34},
doi = {10.1073/pnas.2503779122}
}
EUVIMED